STOCK TITAN

WW International (WW) Stock Price, News & Analysis

WW NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
83 252 sessions, November 10, 2025 to November 10, 2026
Largest daily move
+26.8% close of May 22, 2026
1-year change
-58.6% closing prices, November 10, 2025 to November 10, 2026
1-month change
-19.1% closing prices, October 9, 2026 to November 10, 2026

Company Description

WW International, Inc. (WeightWatchers) is a science-based weight management company that focuses on long-term weight health. Traded under the symbol WW, the company is widely known as WeightWatchers and operates in the diet and weight reducing centers industry. According to multiple company disclosures, WeightWatchers describes itself as the global leader in science-backed weight management, offering an integrated support system that combines scientific expertise, medication access when clinically appropriate, digital tools, and human connection.

WeightWatchers has more than 60 years of experience in commercial weight management and states that it is the most studied commercial weight management program in the world. Since 1963, the company reports that it has used science to support members in reaching and sustaining their goals, delivered through what it calls the No. 1 U.S. doctor-recommended weight-loss program. Members can engage with WeightWatchers directly as individuals or through WeightWatchers for Business, a full-spectrum platform for employers, health plans, and payers.

Business model and offerings

Based on its public communications and earnings definitions, WeightWatchers organizes its activities around two primary subscription-based businesses:

  • Behavioral business – provides subscriptions to the company’s digital product offerings, with the option to add unlimited access to in-person or virtual workshops. This side of the business focuses on behavior change, nutrition guidance, activity, and community support without requiring members to use prescription medications.
  • Clinical business – provides subscriptions to clinical product offerings delivered by WeightWatchers Clinic, combined with the company’s digital subscription products and unlimited workshop access. This business integrates medical care for obesity and metabolic health, including prescriptions for GLP‑1 weight management medications and other treatments when clinically appropriate.

The company states that it generates the majority of its revenue in the form of subscription revenues, which it further breaks down into Behavioral Subscription Revenues and Clinical Subscription Revenues. It also reports Other Revenues from licensing, franchise fees with respect to commitment plans and royalties, publishing, and other activities.

Integrated GLP‑1 platform and Med+ program

Recent company announcements emphasize WeightWatchers’ shift toward what it calls the GLP‑1 era of weight health. Through its affiliated WeightWatchers Clinic, the company offers WeightWatchers Med+, a dedicated GLP‑1 medical program. According to WeightWatchers, Med+ provides eligible members with access to board‑certified physicians and clinicians who specialize in obesity and metabolic health, write prescriptions for FDA‑approved GLP‑1 medications when appropriate, and deliver ongoing medical guidance.

Med+ is paired with the GLP‑1 Success Program, which the company describes as a structured behavioral, nutritional, and lifestyle support program designed for people using GLP‑1 medications. WeightWatchers reports that this integrated model combines access to clinicians, evidence‑based behavioral science, coaching, community support, and purpose‑built digital tools to help members stay engaged, manage side effects, and achieve better results than medication alone.

WeightWatchers has also announced access to an oral formulation of Wegovy through its integrated GLP‑1 platform, positioning this as an expansion of its GLP‑1 treatment options. The company highlights its status as a NovoCare Recognized Care Provider for delivering FDA‑approved GLP‑1 medications alongside clinical care.

Digital platform, app, and technology features

WeightWatchers delivers its programs through a redesigned digital platform and mobile app experience. The firm describes this experience as uniting GLP‑1 prescribing, personalized nutrition, behavioral support, coaching, and community in a single integrated environment. The app and digital tools are intended to help members track habits, monitor progress, and access support.

Among the features the company has publicly described are:

  • Weight Health Score – an evidence‑based metric that converts daily habits into a simple score. It draws on inputs such as body composition, nutrition, activity, and sleep, using data from connected devices and apps to give members a clearer view of which habits are driving overall progress.
  • AI Body Scanner – an AI‑powered body scan that tracks changes in fat and muscle mass over time, offering insights beyond what a traditional scale can provide, particularly for members using GLP‑1 medications.
  • Exclusive fitness content – access to fitness programming within the app, including strength and functional movement content from The LIFTED Method by Holly Rilinger, designed to support members at different life stages and use cases, such as menopause or GLP‑1 use.
  • Modes – configurable program modes (such as All‑In Mode, Lose Mode, and Maintain Mode) that adjust the level and type of support as members move through different phases of their weight journey.

Clinical care, programs, and community

In addition to its core weight management program, WeightWatchers has described several specialized offerings. These include:

  • WeightWatchers Clinic – a telehealth‑based clinical program that integrates medical care, GLP‑1 prescriptions for eligible members, and the behavioral WeightWatchers program. The company cites internal and clinical trial data indicating significant weight loss and improvements in health and quality‑of‑life metrics among participants.
  • WeightWatchers for Menopause – a program designed to support women from perimenopause through post‑menopause. It combines medical care from menopause‑trained clinicians, access to evidence‑based treatments such as hormone therapy and GLP‑1 medications when appropriate, a tailored version of the Points Program, fitness focused on strength and stability, and workshops led by coaches familiar with this life stage.
  • Diabetes‑focused offerings – the company references a diabetes program that, in combination with continuous glucose monitoring in a clinical trial, showed improvements in HbA1c and reductions in medication use for some members.
  • Community and coaching – WeightWatchers repeatedly emphasizes its global network of coaches and community support. Members can join small, coach‑led groups, including groups focused on GLP‑1 use, menopause, nutrition, or movement. The company positions human connection as a core element of its model, alongside digital tools and clinical care.

WeightWatchers for Business and employer solutions

Through WeightWatchers for Business, the company offers what it calls a full‑spectrum weight health platform for employers, health plans, and payers. Public materials describe this offering as combining science‑backed behavior change programs, access to telehealth care, and support for medication management for eligible members. WeightWatchers reports that it has served corporate clients across industries for decades and positions this business as a way for organizations to improve workforce health, manage healthcare costs, and drive measurable health outcomes.

The company has published an annual report for WeightWatchers for Business that highlights outcomes such as weight loss, improvements in quality‑of‑life measures, and engagement rates, based on internal analyses and clinical studies funded by the company.

Collaborations and ecosystem

WeightWatchers has announced collaborations intended to support its integrated care model. One example is a collaboration with Amazon Pharmacy, under which WeightWatchers Clinic members can access real‑time medication availability, automatic coupon savings, and home delivery for weight management medications. The company states that this integration is designed to make access to medications faster, simpler, and more convenient for members, while pairing medication access with its nutrition, behavior change, and community programs.

WeightWatchers has also introduced the WeightWatchers Awards, which recognize health and wellness products that the company’s experts and members use in weight health journeys. These awards highlight items such as food products, meal prep tools, and movement equipment, evaluated using criteria like nutritional quality, accessibility, affordability, and support for sustainable habits.

Capital structure, bankruptcy emergence, and listing status

In 2025, WW International, Inc. underwent a court‑supervised financial reorganization. According to a Form 8‑K filed on June 25, 2025, the company and certain subsidiaries filed voluntary Chapter 11 petitions to implement a prepackaged plan of reorganization focused on restructuring secured debt. The United States Bankruptcy Court for the District of Delaware confirmed the plan, and the company states that it emerged from the Chapter 11 cases on June 24, 2025, applying fresh start accounting as of that date.

As part of the plan, the company’s previously outstanding equity securities, including its old common stock, were canceled, released, and extinguished. On the effective date of the plan, the company issued new common stock to holders of first lien claims and to holders of existing equity interests, as described in the filing. The same Form 8‑K notes that, following emergence, the company’s common stock traded under the symbol WGHTQ on OTC Markets.

Subsequently, a Form 25 filed by Nasdaq Stock Market LLC on July 3, 2025, states that Nasdaq removed from listing and registration the company’s common stock described as “Old Common Stock, which was cancelled in bankruptcy proceeding.” Later company news releases refer to WW International, Inc. as trading on Nasdaq under the symbol WW, indicating that the stock returned to a Nasdaq listing under that symbol after the restructuring and the cancellation of the prior listed shares.

Geographic reach and operations

WeightWatchers describes itself as the only weight health platform with worldwide scale, serving millions of members globally. It reports more than 50 years of international presence and notes that it operates through digital offerings, in‑person workshops, dedicated coaches, and local teams across international markets. The company also mentions select partnerships and licensing agreements in some markets.

Geographically, earlier descriptions indicate that the company generates key revenue from North America and additional revenue from international markets. Within its international operations, the company focuses on adapting its science‑backed programs to local cultures while maintaining consistent scientific and clinical standards.

Research, evidence base, and positioning

Across its public communications, WeightWatchers emphasizes its research base and clinical validation. It cites more than 60 years of experience, over 180 published studies, and dozens of randomized controlled trials related to its programs and outcomes. The company uses this evidence to support its positioning as a science‑backed, holistic weight management platform that integrates behavior change, clinical care, medication access when appropriate, and community support.

In a market that it describes as crowded with contradictory advice, isolated apps, and one‑size‑fits‑all solutions, WeightWatchers presents its approach as personalized and grounded in empathy, with the goal of helping members feel better in their bodies and live longer, healthier lives.

Key concepts and terminology from company disclosures

  • Behavioral Subscription Revenues – fees associated with subscriptions for Behavioral offerings.
  • Clinical Subscription Revenues – fees associated with subscriptions for Clinical offerings provided by WeightWatchers Clinic, combined with digital subscriptions and workshops.
  • Other Revenues – revenues from licensing, franchise fees with respect to commitment plans and royalties, publishing, and other revenues.
  • Behavioral business – subscriptions to digital products with optional workshops.
  • Clinical business – subscriptions to clinical offerings plus digital products and workshops.
  • Incoming Subscribers – subscribers in company‑owned operations at a given period start.
  • End of Period Subscribers – subscribers in company‑owned operations at a given period end.
  • Monthly Subscription Revenues Per Average Subscriber – monthly subscription fees divided by average subscriber counts, used by management to monitor revenue trends per subscriber.

Stock Performance

$12.60
+4.83%
+0.58
After hoursChange vs the $12.02 closeLast updated: November 10, 2026 at 19:56
-58.6%
Performance 1 year
$126.0M

WW International (WW) closed at $12.02 on November 10, 2026. Over the past 12 months, the price has lost 58.6%.

See what a $1,000 investment in WW would be worth today

Average down calculator for WW

WW Metrics & Rankings

Price returns through November 10, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Insider Radar

Net Buyers
90-Day Summary
24,735
Shares Bought
0
Shares Sold
3
Transactions
Most Recent Transaction
BYE STEPHEN J (President and CEO) bought 12,500 shares @ $11.01 on November 10, 2026

Insider buying activity at WW International over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.

Based on SEC Form 4 filings over the last 90 days.

Financial Highlights

WW International reported net income of $1.1B in FY2025. The current ratio was 1.69, measuring current assets divided by current liabilities.

$1.1B
Net Income (FY2025)
—
Revenue (FY2025)
—
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for WW.

Short Interest History

Last 12 Months

Short interest in WW International (WW) currently stands at 1.9 million shares, down 3.0% from the previous reporting period, representing 20.5% of the float. Since November 2025, short interest has increased by 279.5%.

Days to Cover History

Last 12 Months

Days to cover for WW International (WW) currently stands at 11.3 days, up 112.6% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 801.6%. Across the settlements charted above, it has ranged from 1.3 to 18.6 days.

WW Company Profile & Sector Positioning

WW International (WW) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the NASDAQ.

Investors comparing WW often look at related companies in the same sector, including Park Dental Partners, Inc. (PARK), The Joint Corp. (JYNT), Basel Medical Group Ltd (BMGL), Community Health Systems, Inc. (CYH), and Auna S.A. (AUNA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate WW's relative position within its industry.

Frequently Asked Questions

The current stock price of WW International (WW) is $12.60 in after-hours trading as of November 10, 2026.

The market cap of WW International (WW) is approximately $126.0M. Learn more about what market capitalization means .

The FY2025 net income of WW International (WW) is $1.1B, from its most recent completed fiscal year.

The current ratio of WW International (WW), current assets divided by current liabilities, was 1.69 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

WW International, Inc., commonly known as WeightWatchers, operates a science-backed weight management platform. It offers subscription-based behavioral and clinical programs that combine digital tools, nutrition and lifestyle guidance, community support, and, when clinically appropriate, access to weight management medications through WeightWatchers Clinic.

According to the company’s own definitions, WeightWatchers generates most of its revenue from subscription fees. These include Behavioral Subscription Revenues from digital offerings with optional workshops and Clinical Subscription Revenues from WeightWatchers Clinic offerings combined with digital subscriptions and workshops. The company also reports Other Revenues from licensing, franchise fees, royalties, publishing, and other sources.

The Behavioral business provides subscriptions to digital product offerings with the option to add unlimited access to workshops, focusing on behavior change, nutrition, and community support. The Clinical business provides subscriptions to clinical offerings delivered by WeightWatchers Clinic, combined with digital products and workshops, and includes medical care for obesity and metabolic health, including GLP‑1 prescriptions when clinically appropriate.

WeightWatchers Med+ is the company’s dedicated GLP‑1 medical program offered through WeightWatchers Clinic. It gives eligible members access to board‑certified physicians and clinicians who specialize in obesity and metabolic health, prescribe FDA‑approved GLP‑1 medications when appropriate, and provide ongoing medical guidance. Every Med+ member prescribed GLP‑1s also receives the GLP‑1 Success behavioral support program.

WeightWatchers integrates GLP‑1 medications through its Clinical business and WeightWatchers Med+ program. The company states that it combines access to GLP‑1 prescriptions with evidence‑based behavioral programs, coaching, digital tools, and community support. It has also announced access to an oral formulation of Wegovy through its integrated GLP‑1 platform and describes itself as a NovoCare Recognized Care Provider for delivering FDA‑approved GLP‑1 medications with clinical care.

WeightWatchers delivers its programs through a digital platform and mobile app. Public descriptions highlight features such as the Weight Health Score, which summarizes daily habits into a score using data like body composition, nutrition, activity, and sleep; an AI Body Scanner that tracks changes in fat and muscle mass; exclusive fitness content; and configurable Modes that adjust support levels as members move between weight loss and maintenance phases.

WeightWatchers for Business is a full‑spectrum weight health platform designed for employers, health plans, and payers. The company describes it as combining science‑backed behavioral programs, access to telehealth care, and support for medication management for eligible members. It positions this offering as a way for organizations to improve workforce health, manage costs, and achieve measurable health outcomes.

Yes. A Form 8‑K filed on June 25, 2025 states that WW International, Inc. and certain subsidiaries filed voluntary Chapter 11 petitions to implement a prepackaged plan of reorganization focused on restructuring secured debt. The company reports that the plan became effective and it emerged from the Chapter 11 cases on June 24, 2025, applying fresh start accounting from that date.

According to the June 25, 2025 Form 8‑K, all equity securities in the company outstanding prior to the effective date of the plan, including the old common stock, were canceled, released, and extinguished. On the effective date, the company issued new common stock to holders of allowed first lien claims and to holders of existing equity interests, as specified in the plan of reorganization.

A Form 25 filed by Nasdaq on July 3, 2025 indicates that Nasdaq removed from listing and registration the company’s old common stock, which was canceled in the bankruptcy proceeding. Later company news releases describe WW International, Inc. as trading on the Nasdaq Stock Market under the symbol WW, indicating that the company’s shares trade on Nasdaq under that symbol following the restructuring.

Company disclosures state that WeightWatchers has more than 60 years of experience in weight management and that, since 1963, it has used science to support members in reaching and sustaining their goals. It also describes itself as the most studied commercial weight management program in the world, based on its body of published research and clinical trials.

WeightWatchers states that members can access its solutions directly as individuals or through WeightWatchers for Business, which works with employers, health plans, and payers. The company offers digital programs, workshops, clinical care through WeightWatchers Clinic for eligible members, and specialized offerings such as menopause and diabetes‑focused programs.